Employees: 02 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2006-09-20 (19 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LE CELLIER (44850), Loire-Atlantique
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
E.U.R.L. PHARMACIE SEILLER : revenue, balance sheet and financial ratios
E.U.R.L. PHARMACIE SEILLER is a French company
founded 19 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LE CELLIER (44850),
this company of category PME
shows in 2023 a revenue of 1.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - E.U.R.L. PHARMACIE SEILLER (SIREN 492304803)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
1 421 161 €
N/C
N/C
N/C
N/C
N/C
N/C
Net income
26 329 €
20 712 €
46 644 €
80 459 €
101 778 €
83 117 €
95 193 €
54 392 €
88 570 €
EBITDA
N/C
N/C
97 400 €
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
3.3%
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, E.U.R.L. PHARMACIE SEILLER generates positive net income of 26 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 89 k€ -> 26 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
26 329 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 102%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 45%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
101.708%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
44.568%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
526.174
377.485
237.868
172.612
130.313
152.728
126.551
114.444
101.708
Financial autonomy
14.354
19.142
26.328
32.823
38.994
35.444
39.927
41.088
44.568
Repayment capacity
None
None
None
None
None
None
8.633
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
6.55%
None%
None%
Sector positioning
Debt ratio
101.712025
2023
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Average
In 2025, the debt ratio of E.U.R.L. PHARMACIE SEILLER (101.71) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
44.57%2025
2023
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Average
In 2025, the financial autonomy of E.U.R.L. PHARMACIE SEILLER (44.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
8.63 years2023
2023
Q1: 0.95 years
Med: 3.58 years
Q3: 7.48 years
Average
In 2023, the repayment capacity of E.U.R.L. PHARMACIE SEILLER (8.63) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 217.48. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
101.481
112.981
134.269
145.125
190.905
195.096
206.766
191.706
217.48
Interest coverage
None
None
None
None
None
None
3.736
None
None
Sector positioning
Liquidity ratio
217.482025
2023
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Good+6 pts over 3 years
In 2025, the liquidity ratio of E.U.R.L. PHARMACIE SEILLER (217.48) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
3.74x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Good
In 2023, the interest coverage of E.U.R.L. PHARMACIE SEILLER (3.7x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution E.U.R.L. PHARMACIE SEILLER
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
156 186 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
29
0
0
Customer payment term (days)
112
162
133
200
171
142
6
0
0
Supplier payment term (days)
755
888
936
946
848
1060
39
0
0
Positioning of E.U.R.L. PHARMACIE SEILLER in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of E.U.R.L. PHARMACIE SEILLER is estimated at
418 239 €
(range 283 819€ - 656 275€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
283k€418k€656k€
418 239 €Range: 283 819€ - 656 275€
NAF 5 année 2025
Valuation method used
Net Income Multiple
26 329 €
×
15.9x
=418 239 €
Range: 283 819€ - 656 275€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare E.U.R.L. PHARMACIE SEILLER with other companies in the same sector:
Frequently asked questions about E.U.R.L. PHARMACIE SEILLER
What is the revenue of E.U.R.L. PHARMACIE SEILLER ?
The revenue of E.U.R.L. PHARMACIE SEILLER in 2023 is 1.4 M€.
Is E.U.R.L. PHARMACIE SEILLER profitable?
Yes, E.U.R.L. PHARMACIE SEILLER generated a net profit of 26 k€ in 2025.
Where is the headquarters of E.U.R.L. PHARMACIE SEILLER ?
The headquarters of E.U.R.L. PHARMACIE SEILLER is located in LE CELLIER (44850), in the department Loire-Atlantique.
Where to find the tax return of E.U.R.L. PHARMACIE SEILLER ?
The tax return of E.U.R.L. PHARMACIE SEILLER is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does E.U.R.L. PHARMACIE SEILLER operate?
E.U.R.L. PHARMACIE SEILLER operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart